Has Stephanie Vanterpool, MD received payments from drug or device companies?

Yes. Drug and device makers reported $71,752 in general payments to Stephanie Vanterpool, MD across 424 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephanie Vanterpool, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephanie Vanterpool, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephanie Vanterpool, MD

Pain Medicine · Knoxville, TNNPI 1659595270

Payments from drug & device makers

$71,752in general payments, 2019–2025

Across 424 payments — averaging $169.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nevro Corp.$29K
Boston Scientific$22K
Pfizer$7K
Saluda Medical Americas, Inc.$3K
Medtronic$2K
Abbott$2K
plus $7K from 35 others

$105in research payments, 2019–2025

Across 1 payment — averaging $104.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Saluda Medical Americas, Inc.$105

What the payments were for

Consulting fees$14,25021%
Speaking & faculty fees$27,06339%
Travel & lodging$14,18721%
Food & beverage$13,21819%
Entertainment$350%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nevro Corp.	76	$28,877
Boston Scientific	152	$21,601
Pfizer	7	$6,981
Saluda Medical Americas, Inc.	11	$3,432
Medtronic(2 entities)	25	$2,179
Abbott	47	$2,054
Vertiflex, Inc.	10	$1,790
Biotronik NRO, Inc.	10	$1,731
MML US, Inc.	2	$493
SPR Therapeutics, Inc	9	$469
Stimwave Technologies Incorporated	7	$330
Spinefrontier, Inc.	2	$208
Vertos Medical, Inc.	4	$185
Pacira Pharmaceuticals Incorporated	6	$144
Tersera Therapeutics LLC	6	$116
Curonix LLC	1	$109
Avanos Medical	4	$94
Scilex Pharmaceuticals Inc.	6	$92
Nalu Medical, Inc.	5	$86
Averitas Pharma Inc.	2	$76
Biohaven Pharmaceutical Holding Company Ltd.	3	$61
Innovation Technologies Inc	1	$58
GRT US Holding, Inc.	1	$58
Vertex	3	$56
Globus Medical	2	$53
Relievant Medsystems, Inc.	2	$45
Painteq LLC	2	$43
Zyla Life Sciences, Inc.	3	$38
Ipsen Biopharmaceuticals, Inc	2	$37
Foundation Fusion Solutions, LLC	1	$35
Amgen(2 entities)	2	$33
Trevena, Inc.	1	$28
Si-bone, Inc.	1	$27
Convatec Inc.	1	$25
Kowa Pharmaceuticals America, Inc.	1	$22
Stratus Medical, LLC	1	$18
Takeda Pharmaceuticals U.S.A., Inc.	1	$16
AbbVie	1	$15
Collegium Pharmaceutical, Inc.	1	$13
Merit Medical Systems Inc	1	$13
Almatica Pharma LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Senza Spinal Cord Stimulation System$22,161
SPECTRA WAVEWRITER$13,815
Evoke$3,007
GENERAL - THERAPIES$2,997
Omnia$2,478
Superion ISS$1,606
Prospera$1,523
GENERAL PAIN MANAGEMENT$1,417
INTELLIS$1,292
Neuromodulation Dspsbls and Accs$506
ReActiv8$493
ETERNA$446
Evoke SCS$271
Infinion 16$167
mild Device Kit$130
WaveWriter Alpha Prime 16$124
SPRINT PNS System$123
StimQ Receiver Stimulator Kit Channel A US w Receiver$117
StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$117
StimQ Freedom 8A Receiver Kit Channel A US w Receiver$117

How this compares

$71,752 in reported general payments places this provider in the 95th percentile of 112 pain medicine providers in Tennessee.

See all pain medicine providers in Tennessee →

Medicare billing

Part B allowed, 2024

$74,425

Medicare patients

182

Services billed

1,510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Potassium	21	$63,386
Fentanyl	34	$4,123
Clobetasol Propionate	14	$1,777
Morphine Sulfate ErMorphine Sulfate	34	$1,153
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	39	$825
Morphine Sulfate	12	$532
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	19	$416
Pregabalin	11	$324

Paid to pharmacies, not to this prescriber.

Other pain medicine in Knoxville

Joseph DichiaraKnoxville$102K
Jason BuehlerKnoxville$20K
Kyle SnyderKnoxville$8K
James ChooKnoxville$5K
George MearsKnoxville$4K
Matthew VanceKnoxville$3K
Herbert MeltzerNashville$974K
Damita BryantNashville$506K
Shravani DurbhakulaNashville$468K
Marc HuntoonNashville$37K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →